NZ208857A - Hydrohalic salts of endo-8,8-dialkyl-6,7-exo-epoxy-8- azabicyclo(3.2.1) oct-3-yl alkylcarboxylate compounds and pharmaceutical compositions - Google Patents
Hydrohalic salts of endo-8,8-dialkyl-6,7-exo-epoxy-8- azabicyclo(3.2.1) oct-3-yl alkylcarboxylate compounds and pharmaceutical compositionsInfo
- Publication number
- NZ208857A NZ208857A NZ208857A NZ20885784A NZ208857A NZ 208857 A NZ208857 A NZ 208857A NZ 208857 A NZ208857 A NZ 208857A NZ 20885784 A NZ20885784 A NZ 20885784A NZ 208857 A NZ208857 A NZ 208857A
- Authority
- NZ
- New Zealand
- Prior art keywords
- exo
- epoxy
- endo
- azabicyclo
- formula
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 48
- 230000002048 spasmolytic effect Effects 0.000 claims abstract description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 20
- OCAIYHCKLADPEG-UHFFFAOYSA-N propan-2-yl pentanoate Chemical compound CCCCC(=O)OC(C)C OCAIYHCKLADPEG-UHFFFAOYSA-N 0.000 claims description 16
- 150000001350 alkyl halides Chemical class 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000002911 mydriatic effect Effects 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- -1 compound bromide salt Chemical class 0.000 claims description 5
- 230000000968 intestinal effect Effects 0.000 claims description 5
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 4
- FIMXSEMBHGTNKT-UHFFFAOYSA-N Scopine Natural products CN1C2CC(O)CC1C1C2O1 FIMXSEMBHGTNKT-UHFFFAOYSA-N 0.000 claims description 3
- 230000017858 demethylation Effects 0.000 claims description 3
- 238000010520 demethylation reaction Methods 0.000 claims description 3
- FIMXSEMBHGTNKT-RZVDLVGDSA-N scopine Chemical compound C([C@@H]1N2C)[C@H](O)C[C@@H]2[C@@H]2[C@H]1O2 FIMXSEMBHGTNKT-RZVDLVGDSA-N 0.000 claims description 3
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 claims description 2
- 150000001263 acyl chlorides Chemical class 0.000 claims description 2
- 238000005804 alkylation reaction Methods 0.000 claims description 2
- 230000001988 toxicity Effects 0.000 claims description 2
- 231100000419 toxicity Toxicity 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 description 18
- 229940088506 buscopan Drugs 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 238000007912 intraperitoneal administration Methods 0.000 description 11
- 210000003405 ileum Anatomy 0.000 description 9
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000005557 antagonist Substances 0.000 description 7
- 150000003842 bromide salts Chemical class 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 5
- XMLNCADGRIEXPK-KUMOIWDRSA-M chembl2146143 Chemical compound [Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C)C(=O)C(CO)C1=CC=CC=C1 XMLNCADGRIEXPK-KUMOIWDRSA-M 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229930003347 Atropine Natural products 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 229960000396 atropine Drugs 0.000 description 4
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 4
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 4
- 229910001626 barium chloride Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 229960004373 acetylcholine Drugs 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JOTRMYCCALXLNJ-UHFFFAOYSA-N 3-ethyl-4-methylpentanoic acid Chemical compound CCC(C(C)C)CC(O)=O JOTRMYCCALXLNJ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000001022 anti-muscarinic effect Effects 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000012649 demethylating agent Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- PITHYUDHKJKJNQ-UHFFFAOYSA-N 2-propylpentanoyl chloride Chemical compound CCCC(C(Cl)=O)CCC PITHYUDHKJKJNQ-UHFFFAOYSA-N 0.000 description 1
- YQBQUZUVGZHHOC-UHFFFAOYSA-N CCCCC(OC(C)C)=O.Br Chemical compound CCCCC(OC(C)C)=O.Br YQBQUZUVGZHHOC-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940124388 antispastic drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003551 muscarinic effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001179 pupillary effect Effects 0.000 description 1
- 229950009846 scopolamine butylbromide Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22238/83A IT1194343B (it) | 1983-07-26 | 1983-07-26 | Sali di endo-8,8-dialchil-8-azoniabiciclo (3.2.1) ottan-6,7-esso-epossi-3-alchilcarbossilati,processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ208857A true NZ208857A (en) | 1988-05-30 |
Family
ID=11193504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ208857A NZ208857A (en) | 1983-07-26 | 1984-07-10 | Hydrohalic salts of endo-8,8-dialkyl-6,7-exo-epoxy-8- azabicyclo(3.2.1) oct-3-yl alkylcarboxylate compounds and pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4558054A (enExample) |
| EP (1) | EP0133218B1 (enExample) |
| JP (1) | JPS6042382A (enExample) |
| AT (1) | ATE38989T1 (enExample) |
| AU (1) | AU562763B2 (enExample) |
| CA (1) | CA1248956A (enExample) |
| DE (1) | DE3475402D1 (enExample) |
| DK (1) | DK162285C (enExample) |
| IT (1) | IT1194343B (enExample) |
| NZ (1) | NZ208857A (enExample) |
| ZA (1) | ZA845308B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1190133B (it) * | 1986-06-19 | 1988-02-10 | Chiesi Farma Spa | Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
| US6706726B2 (en) * | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| PE20060826A1 (es) * | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2962499A (en) * | 1957-07-03 | 1960-11-29 | Endo Lab | Certain esters of tropine and tropinium salts |
| DE1795818C2 (de) * | 1966-01-26 | 1980-07-10 | C.H. Boehringer Sohn, 6507 Ingelheim | Quartärsalze des N-Äthylnorscopolamin |
| DE1670048C3 (de) * | 1966-01-26 | 1980-09-04 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue Norscopolaminderivate |
| GB1413484A (en) * | 1972-04-18 | 1975-11-12 | Angeli Inst Spa | Scopolamine derivatives |
| IT1140998B (it) * | 1980-06-18 | 1986-10-10 | Valeas Ind Chimica E Farmaceut | Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1. chiusa par. quadrata-ottan-3-alchilcarbossilati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo |
-
1983
- 1983-07-26 IT IT22238/83A patent/IT1194343B/it active
-
1984
- 1984-07-05 AT AT84107838T patent/ATE38989T1/de active
- 1984-07-05 EP EP84107838A patent/EP0133218B1/en not_active Expired
- 1984-07-05 DE DE8484107838T patent/DE3475402D1/de not_active Expired
- 1984-07-06 US US06/628,398 patent/US4558054A/en not_active Expired - Fee Related
- 1984-07-10 ZA ZA845308A patent/ZA845308B/xx unknown
- 1984-07-10 NZ NZ208857A patent/NZ208857A/en unknown
- 1984-07-16 CA CA000458985A patent/CA1248956A/en not_active Expired
- 1984-07-25 DK DK363284A patent/DK162285C/da active
- 1984-07-25 AU AU31163/84A patent/AU562763B2/en not_active Ceased
- 1984-07-26 JP JP59154184A patent/JPS6042382A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DK363284D0 (da) | 1984-07-25 |
| AU3116384A (en) | 1985-01-31 |
| DE3475402D1 (en) | 1989-01-05 |
| ATE38989T1 (de) | 1988-12-15 |
| IT8322238A1 (it) | 1985-01-26 |
| EP0133218A3 (en) | 1986-12-30 |
| DK363284A (da) | 1985-01-27 |
| ZA845308B (en) | 1985-02-27 |
| DK162285C (da) | 1992-03-02 |
| CA1248956A (en) | 1989-01-17 |
| EP0133218A2 (en) | 1985-02-20 |
| IT8322238A0 (it) | 1983-07-26 |
| DK162285B (da) | 1991-10-07 |
| US4558054A (en) | 1985-12-10 |
| JPH0331199B2 (enExample) | 1991-05-02 |
| JPS6042382A (ja) | 1985-03-06 |
| IT1194343B (it) | 1988-09-14 |
| EP0133218B1 (en) | 1988-11-30 |
| AU562763B2 (en) | 1987-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0491664B1 (en) | Indole derivatives as serotonin antagonists | |
| US4803199A (en) | Pharmaceutically useful heterocyclic and carbocyclic acid esters and amides of alkylene bridged piperidines | |
| US4535157A (en) | Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone | |
| CA2172616C (en) | Tropyl 7-azaindol-3-ylcarboxyamides as antitussive agent | |
| NZ235306A (en) | Thienylacetic acid esters and pharmaceutical compositions | |
| BG107930A (bg) | Хин"клидинови карбама'ни производни и използван...'о им ка'о м3 ан'агони''и | |
| NZ241961A (en) | Various (aza) bicycloalkyl esters of polycyclic (hetero)aryl and cycloalkyl carboxylic acids; preparatory processes and pharmaceutical compositions | |
| PL114723B1 (en) | Proces for preparing novel derivatives of morphine | |
| US4427676A (en) | Thiomorpholine derivatives | |
| CS247094B2 (en) | Preparation method of 5,11-dihydro-11-(((methyl-4-piperidinyl)amino)carbonyl)-6h-dibenz(b,e)-azepin-6-on | |
| NZ208857A (en) | Hydrohalic salts of endo-8,8-dialkyl-6,7-exo-epoxy-8- azabicyclo(3.2.1) oct-3-yl alkylcarboxylate compounds and pharmaceutical compositions | |
| US5258392A (en) | 3-quinuclidine derivatives | |
| IL100432A (en) | Dihydrobenzofuran carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| EP0339669A1 (en) | Process for preparing indole-3-carboxylic acid esters of trans-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one | |
| EP0042365A1 (en) | Salts of endo-8-methyl-8-syn-alkyl-8-azoniabicyclo-(3.2.1)-octane-3-alkylcarboxylates, process for their preparation and therapeutic compositions containing them | |
| NZ204451A (en) | N-(2-methoxyethyl)-noroxymorphone and acid-addition salts thereof | |
| IE903616A1 (en) | Neuroprotectant Agents | |
| US4235895A (en) | Substituted 5H-dibenz[b,f]azepine | |
| US4281130A (en) | Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate | |
| EP0374919A1 (en) | Morphine derivative | |
| US4233448A (en) | 3-Methoxycarbonyl-2-(2-thienyl)-8-azabicyclo[3.2.1]octane-8-acetamide and salts thereof | |
| US4233449A (en) | 1-(8-Methyl-2-phenyl(or thienyl)-8-azabicyclo[3.2.1]octan-3-yl) ethanone | |
| US4214084A (en) | Ethanopyrrolo[1,2-b]isoquinolines | |
| EP0101633A1 (en) | Pyridinecarboxylic esters of dopamine and of its N-alkyl derivatives | |
| KR940009783B1 (ko) | 항-기관지경련성 활성이 있는 n-알킬-노르트로핀의 에스테르와 그의 제 4 급유도체의 제조방법 |